Error message
Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).AstraZeneca Pharma India
₹7,185.6
-155.05 (-2.11%)
29 September, 2024 02:45 BSE: 506820
NSE: ASTRAZENISIN: INE203A01020
Start SIP in AstraZeneca Pharma India
Start SIPAstraZeneca Pharma India Performance
Day Range
- Low 7,156
- High 7,356
52 Week Range
- Low 4,411
- High 8,040
- Open Price7,300
- Previous Close7,341
- Volume36764
AstraZeneca Pharma India Financials
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 388 | 383 | 306 | 311 | 295 | 285 |
Operating Expenses Qtr Cr | 349 | 334 | 291 | 258 | 228 | 225 |
Operating Profit Qtr Cr | 38 | 49 | 15 | 53 | 67 | 60 |
Depreciation Qtr Cr | 4 | 4 | 4 | 4 | 4 | 4 |
Interest Qtr Cr | 0 | 0 | 1 | 1 | 0 | 0 |
Tax Qtr Cr | -3 | 15 | 5 | 21 | 18 | 6 |
Net Profit Qtr Cr | -12 | 39 | 16 | 52 | 54 | 17 |
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹7,185.6
-155.05 (-2.11%)
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹7,000.93
- 50 Day
- ₹6,815.20
- 100 Day
- ₹6,529.85
- 200 Day
- ₹6,020.62
- 20 Day
- ₹6,942.70
- 50 Day
- ₹6,848.71
- 100 Day
- ₹6,526.29
- 200 Day
- ₹6,030.00
AstraZeneca Pharma India Resistance and Support
PIVOT
₹7,232.32
Resistance | |
---|---|
First Resistance | 7,309.08 |
Second Resistance | 7,432.57 |
Third Resistance | 7,509.33 |
RSI | 55.38 |
MFI | 94.20 |
MACD Single Line | 83.96 |
MACD | 143.88 |
Support | |
---|---|
First Support | 7,108.83 |
Second Support | 7,032.07 |
Third Supoort | 6,908.58 |
AstraZeneca Pharma India Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 41,427 | 858,782 | 20.73 |
Week | 422,132 | 2,144,429 | 5.08 |
1 Month | 108,183 | 830,843 | 7.68 |
6 Month | 43,648 | 906,124 | 20.76 |
AstraZeneca Pharma India Result Highlights
AstraZeneca Pharma India Synopsis
NSE-Medical-Diversified
Astrazeneca Pharma I is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1295.53 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2024. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.Market Cap | 17,964 |
Sales | 1,388 |
Shares in Float | 0.63 |
No of funds | 126 |
Yield | 0.33 |
Book Value | 25.23 |
U/D Vol ratio | 3.1 |
LTDebt / Equity | |
Alpha | 0.11 |
Beta | 0.86 |
AstraZeneca Pharma India Shareholding Pattern
Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|
Promoters | 75% | 75% | 75% | 75% |
Mutual Funds | 4.97% | 3.75% | 2.75% | 2.42% |
Insurance Companies | ||||
Foreign Portfolio Investors | 2.79% | 2.73% | 2.66% | 2.69% |
Financial Institutions/ Banks | ||||
Individual Investors | 15% | 16.34% | 17.09% | 17.44% |
Others | 2.24% | 2.18% | 2.5% | 2.45% |
AstraZeneca Pharma India Management
Name | Designation |
---|---|
Mr. Narayan K Seshadri | Chairperson & Independent Director |
Mr. Sanjeev Kumar Panchal | Executive Director |
Ms. Bhavana Agrawal | Executive Director |
Ms. Sylvia Lorena Varela Ramon | Non Executive Director |
Ms. Hooi Bien Chuah | Non Executive Director |
Ms. Shilpa Divekar Nirula | Independent Director |
Ms. Revathy Ashok | Independent Director |
AstraZeneca Pharma India Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
AstraZeneca Pharma India Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-08-08 | Quarterly Results | |
2024-05-27 | Audited Results & Dividend | |
2024-02-08 | Quarterly Results | |
2023-11-09 | Quarterly Results | |
2023-08-14 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2024-07-05 | FINAL | Rs.24.00 per share(1200%)Dividend |
2023-07-14 | FINAL | Rs.16.00 per share(800%)Dividend |
2022-07-08 | FINAL | Rs.8.00 per share(400%)Final Dividend |
2021-08-20 | INTERIM | Rs.2.00 per share(100%)Interim Dividend |
AstraZeneca Pharma India FAQs
What is Share Price of AstraZeneca Pharma India ?
AstraZeneca Pharma India share price is ₹7,185 As on 29 September, 2024 | 02:31
What is the Market Cap of AstraZeneca Pharma India ?
The Market Cap of AstraZeneca Pharma India is ₹17964 Cr As on 29 September, 2024 | 02:31
What is the P/E ratio of AstraZeneca Pharma India ?
The P/E ratio of AstraZeneca Pharma India is 187.4 As on 29 September, 2024 | 02:31
What is the PB ratio of AstraZeneca Pharma India ?
The PB ratio of AstraZeneca Pharma India is 25.2 As on 29 September, 2024 | 02:31